The COX-2-1195AA genotype is associated with diffuse-type gastric cancer in Korea

Gut and Liver

Volumn 6, Issue 3, 2012, Pages 321-327

  Shin, Woon Geon ^a   Kim, Ha Jung ^a   Cho, Sung Jin ^a   Kim, Hyoung Su ^a   Kim, Kyung Ho ^a   Jang, Myoung Kuk ^a   Lee, Jin Heon ^a   Kim, Hak Yang ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

COX 2; Diffuse type; Polymorphism; Stomach neoplasms

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIFFUSE TYPE STOMACH CANCER; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; INTESTINAL TYPE STOMACH CANCER; KOREA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH CANCER;

EID: 84865414830     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2012.6.3.321     Document Type: Article

References (39)

1. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
2. International Agency for Research on Cancer; WHO/IARC Expert Committee on Cancer Statistics. Infection with Helicobacter pylori. In: IARC; WHO/IARC Expert Committee on Cancer Statistics, eds. IARC monographs on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. Volume 61. Lyon: IARC, 1994:177-240.
3. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402. (Pubitemid 30164342)
4. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-1201. (Pubitemid 36531795)
5. Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-371. (Pubitemid 36929416)
6. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001;36:696-699. (Pubitemid 33040943)
7. Lee SG, Kim B, Choi W, Lee I, Choi J, Song K. Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B-31 C/+ and IL-1RN*2/*2) and gastric cancer/duodenal ulcer in Korean population. Cytokine 2003;21:167-171. (Pubitemid 36677434)
8. Lee JY, Kim HY, Kim KH, et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 2005;225:207-214.
9. Shin WG, Jang JS, Kim HS, et al. Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. J Gastroenterol Hepatol 2008;23:1567-1573.
10. Pereira C, Sousa H, Ferreira P, et al. -765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J Gastroenterol 2006;12:5473-5478.
11. Liu F, Pan K, Zhang X, et al. Genetic variants in cyclooxygenase- 2: expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 2006;130:1975-1984. (Pubitemid 43816953)
12. Saxena A, Prasad KN, Ghoshal UC, Bhagat MR, Krishnani N, Husain N. Polymorphism of -765G > C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H pylori infection: a study from northern India. World J Gastroenterol 2008;14:1498-1503. (Pubitemid 351460161)
13. Hou L, Grillo P, Zhu ZZ, et al. COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population. Anticancer Res 2007;27(6C):4243-4247.
14. Canzian F, Franceschi S, Plummer M, et al. Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur J Cancer Prev 2008;17:178-183. (Pubitemid 351301630)
15. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxy-genase- 1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002;99:13926-13931. (Pubitemid 35215482)
16. Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 2000;6:135-138. (Pubitemid 30064985)
17. Murata H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 1999;94:451-455. (Pubitemid 29084668)
18. Ohno R, Yoshinaga K, Fujita T, et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001;91:1876-1881. (Pubitemid 32424114)
19. Tatsuguchi A, Matsui K, Shinji Y, et al. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol 2004;35:488-495. (Pubitemid 38507087)
20. Sun WH, Yu Q, Shen H, et al. Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J Gastroenterol 2004;10:2809-2813. (Pubitemid 39302994)
21. Szczeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 2004;114:248-253. (Pubitemid 39119020)
22. Zhang X, Miao X, Tan W, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 2005;129:565-576. (Pubitemid 41096644)
23. Pereira C, Medeiros RM, Dinis-Ribeiro MJ. Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? Eur J Gastroenterol Hepatol 2009;21:76-91.
24. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process: first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-6740. (Pubitemid 23006271)
25. Hiyama T, Tanaka S, Kitadai Y, et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002;100:304-308. (Pubitemid 34728988)
26. National Cancer Information Center. Yearly report of Korea on cancer development (2007.1.1-2007.12.31) [Internet]. Ministry of Health and Welfare for Korean Government; c2011 [cited 2010 Jul 16]. Available from: http://www.cancer.go.kr/cms/statics/incidence/index.html.
27. Sobin LH, Wittekind C; International Union Against Cancer. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss, 2002.
28. Ramsay RG, Barton AL, Gonda TJ. Targeting c-Myb expression in human disease. Expert Opin Ther Targets 2003;7:235-248. (Pubitemid 36512023)
29. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
30. Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000;92:569-573. (Pubitemid 30212319)
31. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-405. (Pubitemid 28168738)
32. Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999;44:177-180. (Pubitemid 29219903)
33. Richards FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999;8:607-610. (Pubitemid 29139974)
34. Yun HR, Lee SO, Choi EJ, Shin HD, Jun JB, Bae SC. Cyclooxygenase- 2 polymorphisms and risk of rheumatoid arthritis in Koreans. J Rheumatol 2008;35:763-769. (Pubitemid 351747114)
35. Malaty HM, Kim JG, El-Zimaity HM, Graham DY. High prevalence of duodenal ulcer and gastric cancer in dyspeptic patients in Korea. Scand J Gastroenterol 1997;32:751-754. (Pubitemid 27357424)
36. Chang WK, Kim HY, Kim DJ, et al. Association between Helicobacter pylori infection and the risk of gastric cancer in the Korean population: prospective case-controlled study. J Gastroenterol 2001;36:816-822. (Pubitemid 34036904)
37. Testoni PA, Bonassi U, Bagnolo F, Colombo E, Scelsi R. In diffuse atrophic gastritis, routine histology underestimates Helicobacter pylori infection. J Clin Gastroenterol 2002;35:234-239. (Pubitemid 34913090)
38. Kokkola A, Rautelin H, Puolakkainen P, et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 2000;35:138-141. (Pubitemid 30216581)
39. Yoo JY, Kim N, Park YS, et al. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol 2007;41:751-755. (Pubitemid 47267761)